VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy ; volume:23 ; number:1 ; day:7 ; month:11 ; year:2023 ; pages:1-21 ; date:12.2023
Cancer cell international ; 23, Heft 1 (7.11.2023), 1-21, 12.2023
- Urheber
-
Shekari, Najibeh
Shanehbandi, Dariush
Kazemi, Tohid
Zarredar, Habib
Baradaran, Behzad
Jalali, Seyed Amir
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-023-03116-0
- URN
-
urn:nbn:de:101:1-2024012409184845597180
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shekari, Najibeh
- Shanehbandi, Dariush
- Kazemi, Tohid
- Zarredar, Habib
- Baradaran, Behzad
- Jalali, Seyed Amir
- SpringerLink (Online service)
Ähnliche Objekte (12)
IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
CXCR4 ligands: the next big hit?
Natural killer cells: a promising immunotherapy for cancer
Polyimido Sulfur Compounds as Promising Ligands in Molecular Magnets
Promising Lithography Techniques for Next-Generation Logic Devices
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Exosome-based immunotherapy: a promising approach for cancer treatment
BAP31, a promising target for the immunotherapy of malignant melanomas
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
Next-generation immunotherapy to counteract T-cell exhaustion
IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
CXCR4 ligands: the next big hit?
Natural killer cells: a promising immunotherapy for cancer
Polyimido Sulfur Compounds as Promising Ligands in Molecular Magnets
Promising Lithography Techniques for Next-Generation Logic Devices
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Exosome-based immunotherapy: a promising approach for cancer treatment
BAP31, a promising target for the immunotherapy of malignant melanomas
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
Next-generation immunotherapy to counteract T-cell exhaustion
IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
CXCR4 ligands: the next big hit?
Natural killer cells: a promising immunotherapy for cancer
Polyimido Sulfur Compounds as Promising Ligands in Molecular Magnets
Promising Lithography Techniques for Next-Generation Logic Devices
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
Exosome-based immunotherapy: a promising approach for cancer treatment
BAP31, a promising target for the immunotherapy of malignant melanomas
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy